Biognosys
Business Services · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Wagistrasse 21, Schlieren, Zurich, 8952,...Phone Number
+41 447382040Website
www.biognosys.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Biognosys
Biognosys is a leading global proteomics company specializing in next-generation proteomics solutions utilizing proprietary mass spectrometry technology. They provide a wide range of services including biomarker discovery, drug target validation, and clinical biomarker panels, catering primarily to the pharmaceutical and biotechnology sectors. Their offerings also include high-performance software, peptide kits, and sample preparation reagents to support in-house proteomics research. With a focus on transforming R&D and clinical decision-making, Biognosys aims to power precision medicine through innovative proteomics solutions.Explore more
Biognosys Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biognosys your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Biognosys recently announced quarterly report
Product Launch: Get notified when Biognosys launches new products
Website visits: Recent activity has been detected on your website
Check out if Biognosys is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Biognosys had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Biognosys
Biognosys, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Biognosys has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Biognosys has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Biognosys is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Biognosys is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Biognosys.
Biognosys financials insights
Gather financial insights about Biognosys, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Series A
$3M
2017
Series C
$5M
Biognosys Tech Stack
A closer look at the technologies used by Biognosys
See more technologies
Most Recent Scoops
Partnership
Project
Partnership, Product Development, Research & Development, Business Development, Medical Research
Event
Product Marketing, Events, Engineering, Sales, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Product Marketing, Events, Engineering, Sales, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Facilities Relocation / Expansion
Facilities Relocation/Expansion
Event
Events
Biognosys News & Media
Biognosys Launches Spectronaut 20 and SpectroMine 5, Setting New Benchmarks in Immunopeptidomics
Biognosys launches Spectronaut 20 and SpectroMine 5, advancing immunopeptidomics, unspecific searches, and cloud-ready proteomics workflows at ASMS 2025SISCAPA and Biognosys Announce Strategic Collaboration to Deliver End-to-End High-Sensitivity Targeted Protein Quantification Solutions
SISCAPA and Biognosys partner to deliver end-to-end high-sensitivity targeted protein quantification for biomarker discovery and clinical trials.IonOpticks' Custom Chromatography Column to Become Biognosys' Standard for High-Quality Proteomic Insights
MELBOURNE, Australia and ZURICH, Dec. 5, 2024 /PRNewswire/ -- Today, IonOpticks, a world leading provider of chromatography solutions, and Biognosys, a global leader in mass spectrometry-based proteomics contract research services, announce a long-term supply agreement. Under the...Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress
Biognosys announced its participation in the 23rd Human Proteome Organization (HUPO) World Congress from October 20 to October 24 in Dresden, Germany.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biognosys
Sign Up For FreeTo access detailed company insights
Biognosys is a leading global proteomics company specializing in next-generation proteomics solutions utilizing proprietary mass spectrometry technology. They provide a wide range of services including biomarker discovery, drug target validation, and clinical biomarker panels, catering primarily to the pharmaceutical and biotechnology sectors. Thei... Read More
